Nucleus, a psychedelic data-driven platform, begins to orbit the mental health crisis; Logan Lenz to Captain of the Ship
FORT LAUDERDALE, Florida., January 19, 2022 /PRNewswire/ — Core, a South Florida startup focused on mental health data and technology, today announced its launch. The company, 100% owned by venture capital firm Iter Investments, unveils an entire ecosystem designed to meet people where they are and support them on their mental health journey. The platform is centered around a unique search engine experience, which provides enough space for the process of self-discovery to take place safely and efficiently.
Nucleus is comprised of technology, data, and media assets intended to provide information, education, and opportunity for those seeking a resource for self-discovery and industry insights. Within the platform, participants can assess their emotional health, find treatments, log their experiences, and take full ownership of all their documented health data along the way. All with the goal of empowering patients so they can better understand themselves as they grow and evolve.
Attached to Nucleus, a constellation of companies fuels the ecosystem with even more resources while providing participants with an array of opportunities. The list of assets includes:
- Neuly: A subscription-based data platform for researchers and industry professionals in psychedelics and mental health
- psychedelic investing: A resource providing investors with reports and information covering the growing herbal, entheogenic and psychoactive drug industry
- material academy: A Collection of Training Programs for Wellness Practitioners
- Psyrise: A marketing partner for mental health brands
- Particles: A decentralized community building the future of wellbeing
The creation of Nucleus began when Iter Investments acquired Psychedelic Invest and Neuly in June 2021. Iter Investments Managing Director Dustin Robinson explains, “Nucleus’ acquisition of Psychedelic Invest and Neuly provided Nucleus with the foundation to build a robust ecosystem that captures data and delivers it to a large and growing psychedelic audience.” Since then, the collective team of developers, researchers, and writers have been working in stealth mode to expand the Nucleus universe to help as many people as possible.
Serial Tech and Marketing Entrepreneur, Logan Lenz, later joined as CEO of Nucleus to lead the way as the company ascended. Over the past 20 years, Lenz has founded several startups and worked with brands such as Disney, Coca-Cola and Planet Fitness on their media plans. Then, after more than a decade of creating solutions himself, Logan became a consultant and advisor to numerous healthcare startups. Billions of marketing and advertising dollars spent later, Lenz has amassed a portfolio of success stories ranging from blockchain development to IPOs.
Recently, Psychedelic Invest, using Neuly’s extensive database, launched its 2021 Annual Report – a 100-page example of the platform’s and team’s in-depth analytical capabilities. Additionally, Neuly has undergone a redesign and upgrade to ensure it maintains the most robust, secure and reliable data in the industry.
In the near future, Lenz expects Nucleus to launch an NFT collection with the community and finalize a blockchain bridge that will allow clinics and therapists to integrate health records into the platform and store everything on-chain.
“Over the next few years, I think we’re going to start to see the future of wellness unfold before our very eyes,” Lenz said. Nucleus is well positioned to serve as the foundational layer of what could eventually become a decentralized healthcare system.”
Robinson continued: “The global mental health crisis is arguably the greatest challenge facing the world today. The world is hurting and people need information and support. Nucleus can help all industry players including patients, clinicians, therapists, practitioners, investors, advocates. , and psychedelic companies in a way – all while collaborating and helping propel the entire industry forward.”
For more information, please visit www.withnucleus.com.
This press release (i) is not an offer or a solicitation of an offer to buy or sell any securities or investments, and (ii) does not constitute tax, legal or investment advice.
About Iter Investments
Iter Investments is an investment company deploying capital in and around the burgeoning psychedelic industry. Iter Investments invests with the mission to reinvent the way the mental health and wellbeing industry delivers care. For more information, visit www.iterinvestments.com or email [email protected].
Nucleus is a self-discovery engine. With its proprietary research technology, expansive database, and suite of educational assets, the company hopes to advance transformative health treatments along its mission to help more than one billion people “get back to self”. For more information, visit www.withnucleus.com.
Duration & Company, Inc.
954.723.9350 / [email protected]